Related Experiment Video
Updated: Jun 22, 2026

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291
Published on: December 10, 2016
Mortality and risk stratification in patients with Clostridium difficile-associated diarrhoea
S Bhangu1, A Bhangu, P Nightingale
1Dudley Group of Hospital NHS Trust, Russells Hall Hospitals, Dudley, UK.
Aim:
This study aimed to describe the mortality in hospital patients with a first documented episode of Clostridium difficile-associated diarrhoea (CDAD) and to identify prognostic risk factors.
Method:
A cohort study of 158 patients was carried out with CDAD diagnosed over a 8-month period in a large acute UK teaching hospital. Logistic multivariable regression aided construction of a scoring system to stratify risk of death. The main outcome measure was the 30-day inpatient mortality.
Results:
Most affected patients were medical (n = 101, 64%), with general surgical (n = 30, 19%) and orthopaedic patients (n = 27, 17%) forming the rest. General surgical patients (mean age 78 years) were significantly younger than medical (82 years) or orthopaedic patients (85 years, P = 0.008). Overall 30-day mortality was 38%. 30-day mortality was higher in medical (46%) and orthopaedic patients (37%) compared with general surgical patients (13%, P = 0.006). Most surgical patients were those admitted as an emergency. A scoring system was devised and used within the first 72 h. A point was awarded for each of the following: age > or = 80 years, clinically severe disease (sepsis, peritonitis, > or = 10 episodes of diarrhoea in 24 h), WCC > or = 20 or CRP > or = 150, urea > or = 15, albumin < or = 20. Point counts of 0-1, 2-3 and 4-5 were associated with mortality rates of 22%, 55% and 89% respectively.
Conclusion:
Inpatient mortality from CDAD is high. Variability exists between different specialities. Patients at high risk of death can potentially be identified earlier using clinical and biochemical risk factors.
Related Concept Videos
Dysbiosis of the Gut Microbiota
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Development of Human Microbiota
Inflammatory Bowel Disease III: Crohn's Disease
